Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1968-10-17
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0014-2565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
215-21
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:5597809-Alanine Transaminase,
pubmed-meshheading:5597809-Aspartate Aminotransferases,
pubmed-meshheading:5597809-Female,
pubmed-meshheading:5597809-Fructose-Bisphosphate Aldolase,
pubmed-meshheading:5597809-Humans,
pubmed-meshheading:5597809-Male,
pubmed-meshheading:5597809-Neoplasms
|
pubmed:year |
1967
|
pubmed:articleTitle |
[Glutamic oxalacetic, pyruvic transaminases and aldolase in neoplasms].
|
pubmed:publicationType |
Journal Article
|